Modulatory effect of chiral nonsteroidal anti-inflammatory drugs on apoptosis of human neutrophils

Chirality

Volumn 20, Issue 2, 2008, Pages 159-165

  Zielińska Przyjemska, Małgorzata ^a   Główka, Franciszek K ^a   Klaczyńska, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

2 arylbutyric acid; 2 arylpropionic acid derivatives; Enantiomers; PMN oxidative burst; Polymorphonuclear neutrophils; Racemic mixtures; Reactive oxygen species

Indexed keywords

CARBOXYFLUORESCEIN; CASPASE 3; CASPASE INHIBITOR; FLURBIPROFEN; INDOBUFEN; KETOPROFEN; LIPOCORTIN 5; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUOROMETRY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; STRUCTURE ANALYSIS; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CASPASE 3; CELL MEMBRANE; CELL SURVIVAL; ENZYME ACTIVATION; FLUORESCEINS; FLUOROMETRY; HUMANS; NEUTROPHILS; PHOSPHATIDYLSERINES; PROPIONIC ACIDS; STEREOISOMERISM; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 38549117984     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20516     Document Type: Article

References (31)

1. Marshall JC, Malam Z, Jia S. Modulating neutrophil apoptosis. Novartis Found Symp 2007;280:53-66.
2. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33-44.
3. Rossi AG, Hallett JM, Sawatzky DA, Teixeira MM, Haslett C. Modulation of granulocyte apoptosis can influence the resolution of inflammation. Biochem Soc Trans. 2007;35:288-291.
4. Hofman P. Molecular regulation of neutrophil apoptosis and potential targets for therapeutic strategy against the inflammatory process. Curr Drug Targets Inflamm Allergy 2004;3:1-9.
5. Maianski NA, Maianski AN, Kuijpers TW, Roos D. Apoptosis of neutrophils. Acta Haematol 2004;111:56-66.
6. Akgul C, Moulding DA, Edwards SW. Molecular control of neutrophil apoptosis. FEBS Lett 2001;487:318-322.
7. Vaughan AT, Berti CJ, Villalobos MJ. Surviving apoptosis. Apoptosis 2002;7:173-177.
8. Grodzicky T, Elkon KB. Apoptosis in rheumatic disease. Am J Med 2000;108:73-82.
9. Adachi M, Sakamoto H, Kawamura R, Wang W, Imai K, Shinomura Y. Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histol Histopathol 2007;22:437-442.
10. Swierkot J, Miȩdzybrodzki R, Szymaniec S, Szechinski J. Activation-dependent apoptosis of peripheral blood mononuclear cells from patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 2004;63:599-600.
11. Harris RC, Breyer MD. Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol 2006;1:236-245.
12. Jamali F. Research methodology in NSAID monitoring: plasma concentrations of chiral drugs. J Rheumatol 1988;15:71-74.
13. Hurt AJ, Caldwell J. The metabolic chiral inversion of 2-arylprpionic acids: a novel route with pharmacological consequences. J Pharm Pharmacol 1983;35:693-704.
14. Cooper SA, Reynolds DC, Reynolds B, Hersh EV. Analgesic efficacy and safety of (R)-ketoprofen in postoperative dental pain. J Clin Pharmacol 1998;38:11S-18S.
15. Morihara T, Chu T, Ubeda O, Beech W, Cole GM. Selective inhibition of Abeta42 production by NSAID R-enantiomers. J Neurochem 2002;83:1009-1012.
16. Ferrante H, Thong YH. A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J Immunol Methods 1978;24:389-393.
17. Lowry OH, Rosenbrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
18. Amstad PA, Johnson GL, Lee BW, Dhawan S. An in situ marker for the detection of activated caspases. Biotechnol Lab 2000;18:52-56.
19. Carcia-Calvo ME, Peterson B, Leiting R, Nicholson D. Thornberry N. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998;273:32608-32613.
20. Mosman T. Rapid colorimetric assay for cellular growth and cytotoxicity assay. J Immunol Methods 1983;65:55-63.
21. Fratelli M, Minto M, Crespi A, Erba E, Vandenabeele P, Del Soldato P, Ghezzi P. Inhibition of nuclear factor-κB by a nitro-derivative of flurbiprofen: a possible mechanism for anti-inflammatory and antiproliferative effect. Antioxid Redox Signal 2003;5:229-235.
22. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: a novel target for cancer chemiotherapy? J Cancer Res Clin Oncol 2001;127:411-417.
23. Chan TA. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol 2002;3:166-174.
24. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unestrified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 2000;97:11280-11285.
25. Kabayashi SD, Voyuich JM, Deleo FR. Regulations of the neutrophil-mediated inflammatory response to infection. Microbes Infect 2003;5:1337-1344.
26. Yamashita K, Takahashi A, Kobayashi S, Hirata H, Mesner PW Jr, Kaufmann SH, Yonehara S, Yamamoto K, Uchiyama T, Sasada M. Caspases mediate tumor nectrosis factor-α-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood 1999;93:674-685.
27. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
28. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 1998;92:4808-4818.
29. 2SO- differentiated HL-60 cells. J Biol Chem 2002;277:49965-49975.
30. Wilkie RP, Vissers MC, Dragunow M, Hampton MB. A functional NADPH oxidase prevents caspase involvement in the clearance of phagocytic neutrophils. Infect Immun 2007;75:3256-3263.
31. Raz A. Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer. Biochem Pharmacol 2002;63:343-347.